Alterity Therapeutics Limited
ATH
Classificação em ações
#26160
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Preço da ação
$0.18265392
Valor de mercado
$39.91M
Variação (1 dia)
1.96%
Variação (1 ano)
-47.81%
País
AU
Negociar Alterity Therapeutics Limited (ATH)
Categoria
Healthcare
Histórico de preços das ações de Alterity Therapeutics Limited (ATH)
Preço de fecho mais alto: $0.33 em 2026-10-01
Preço de fecho mais baixo: $13.50 em 2012-09-01
Preço de fecho mais baixo: $13.50 em 2012-09-01
Histórico de preços das ações da Alterity Therapeutics Limited de 2012 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | -12.13% |
| 2025 | 75.00% |
| 2024 | -18.18% |
| 2023 | -37.61% |
| 2022 | -59.70% |
| 2021 | -39.12% |
| 2020 | 63.99% |
| 2019 | -39.67% |
| 2018 | -32.87% |
| 2017 | 8.20% |
| 2016 | -48.69% |
| 2015 | -55.45% |
| 2014 | -69.99% |
| 2013 | 162.07% |
| 2012 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.17 | -4.24% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
